QbD and green metric based HPLC method development and validation of bromocriptine mesylate in bulk product and biological samples

This publication has 31 references indexed in Scilit:

• QbD-steered development and validation of an RP-HPLC method for quantification of ferulic acid: Rational application of chemometric tools
  Journal of Chromatography B, 2020
• High‐dimensional variable screening under multicollinearity
  Stat, 2020
• Chemometrics‐assisted development of a liquid chromatography method for estimation of lapatinib in tablets: A case study on a novel quality concept
  Separation Science Plus, 2019
• Development of a validated liquid chromatographic method for quantification of sorafenib tosylate in the presence of stress‐induced degradation products and in biological matrix employing analytical quality by design approach
  Biomedical Chromatography, 2018
• Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine
  Pharmaceutical Research, 2008
• A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets
  Journal of Chromatography B, 2007
• Estimation of the uncertainty of indirect measurements from the propagation of distributions by using the Monte-Carlo method: An overview
  Chemometrics and Intelligent Laboratory Systems, 2005
• Sensitive method for the quantitative determination of bromocriptine in human plasma by liquid chromatography–tandem mass spectrometry
  Journal of Chromatography B, 2005
• Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism
  European Journal of Drug Metabolism and Pharmacokinetics, 1983
• Effect of flow rates and the slope of the linear concentration gradient on peak areas in high pressure liquid chromatography
  Journal of Chromatography A, 1971